SurgLine Financial Statements From 2010 to 2026

SGLN Stock  USD 0.0001  0.00  0.00%   
SurgLine International's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing SurgLine International's valuation are provided below:
Gross Profit
39.1 K
Market Capitalization
569 K
Enterprise Value Revenue
9.6577
Revenue
113.6 K
Earnings Share
(0.01)
We have found one hundred twenty available fundamental trend indicators for SurgLine International, which can be analyzed and compared to other ratios and to its competition. Self-guided Investors are advised to double-check SurgLine International's current fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 18th of January 2026, Market Cap is likely to grow to about 2.5 M. Also, Enterprise Value is likely to grow to about 2.9 M

SurgLine International Total Revenue

137,196

Check SurgLine International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SurgLine International's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.5 M or Total Revenue of 137.2 K, as well as many indicators such as Price To Sales Ratio of 30.34, Dividend Yield of 0.0 or Days Sales Outstanding of 222. SurgLine financial statements analysis is a perfect complement when working with SurgLine International Valuation or Volatility modules.
  
Build AI portfolio with SurgLine Stock
Check out the analysis of SurgLine International Correlation against competitors.
To learn how to invest in SurgLine Stock, please use our How to Invest in SurgLine International guide.

SurgLine International Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets83.2 K121.5 K102 K
Slightly volatile
Total Current Liabilities984.6 K1.5 M1.6 M
Slightly volatile
Accounts Payable565.2 K453.6 K565.9 K
Slightly volatile
Cash8.2 K8.6 K7.2 K
Slightly volatile
Net Receivables64.4 K92.9 K77.9 K
Slightly volatile
Total Liabilities993.4 K1.5 M1.6 M
Slightly volatile
Total Current Assets78.4 K121.5 K101 K
Slightly volatile
Common Stock3.6 M6.3 M5.1 M
Slightly volatile

SurgLine International Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.5 M2.4 MM
Slightly volatile

SurgLine International Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings393.5 K374.8 K320 K
Slightly volatile
Depreciation60263410.7 K
Slightly volatile
Total Cash From Financing Activities387.4 K363.3 K310.7 K
Slightly volatile
Change To Netincome1.1 MM1.6 M
Slightly volatile
Change To Liabilities235.5 K324.5 K276.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio30.3421.1822.4079
Slightly volatile
Days Sales Outstanding222234240
Slightly volatile
Average Payables610.7 K379.7 K356.2 K
Slightly volatile
Stock Based Compensation To Revenue15.1815.9818.3724
Slightly volatile
Capex To Depreciation0.00620.00650.1132
Slightly volatile
ROIC1.212.031.8877
Slightly volatile
Inventory Turnover4.325.15.434
Very volatile
Days Of Inventory On Hand79.4874.1367.9478
Pretty Stable
Payables Turnover0.120.131.4 K
Slightly volatile
Sales General And Administrative To Revenue20.3921.4727.7108
Slightly volatile
Average Inventory7.2 K7.6 K70.6 K
Slightly volatile
Capex To Revenue0.00.00.0025
Slightly volatile
Cash Per Share0.00.02.0E-4
Slightly volatile
Days Payables OutstandingK2.9 KK
Slightly volatile
Income Quality0.210.150.1867
Slightly volatile
Intangibles To Total Assets0.340.370.4089
Slightly volatile
Current Ratio0.06960.07332.7782
Slightly volatile
Receivables Turnover1.541.62166
Slightly volatile
Average Receivables76.4 K46.4 K49.4 K
Pretty Stable
Revenue Per Share0.00.00.1885
Slightly volatile
Interest Debt Per Share1.0E-41.0E-40.0136
Slightly volatile
Debt To Assets3.483.23.3383
Slightly volatile
Graham Number0.110.120.1347
Slightly volatile
Operating Cycle277292300
Slightly volatile
Days Of Payables OutstandingK2.9 KK
Slightly volatile
Ebt Per Ebit2.521.511.5838
Pretty Stable
Return On Capital Employed1.021.541.495
Slightly volatile
Quick Ratio0.0610.06422.7706
Slightly volatile
Cash Ratio0.00490.00522.016
Slightly volatile
Days Of Inventory Outstanding79.4874.1367.9478
Pretty Stable
Days Of Sales Outstanding222234240
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.781.171.2081
Pretty Stable
Fixed Asset Turnover0.00960.01010.4107
Slightly volatile
Debt Ratio3.483.23.3383
Slightly volatile
Price Sales Ratio30.3421.1822.4079
Slightly volatile
Asset Turnover1.171.2425.9681
Slightly volatile
Gross Profit Margin0.420.40.3477
Slightly volatile

SurgLine International Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.5 M2.4 M2.5 M
Slightly volatile
Enterprise Value2.9 M2.7 M2.9 M
Slightly volatile

About SurgLine International Financial Statements

SurgLine International investors utilize fundamental indicators, such as revenue or net income, to predict how SurgLine Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue130.7 K137.2 K
Cost Of Revenue85.7 K90 K
Stock Based Compensation To Revenue 15.98  15.18 
Sales General And Administrative To Revenue 21.47  20.39 
Ebit Per Revenue(21.07)(22.13)

Pair Trading with SurgLine International

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SurgLine International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SurgLine International will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to SurgLine International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SurgLine International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SurgLine International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SurgLine International to buy it.
The correlation of SurgLine International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SurgLine International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SurgLine International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SurgLine International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether SurgLine International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SurgLine International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surgline International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surgline International Stock:
Check out the analysis of SurgLine International Correlation against competitors.
To learn how to invest in SurgLine Stock, please use our How to Invest in SurgLine International guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SurgLine International. If investors know SurgLine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SurgLine International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(14.63)
The market value of SurgLine International is measured differently than its book value, which is the value of SurgLine that is recorded on the company's balance sheet. Investors also form their own opinion of SurgLine International's value that differs from its market value or its book value, called intrinsic value, which is SurgLine International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SurgLine International's market value can be influenced by many factors that don't directly affect SurgLine International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SurgLine International's value and its price as these two are different measures arrived at by different means. Investors typically determine if SurgLine International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SurgLine International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.